Home > Drug Search >
  • Targets: Elastin (ELN)
  •   > 
Drug Filter
Category:
chemistry (39) biology (3)
Status:
Approved (9) Phase Ⅲ (6) Phase Ⅱ (14) Phase Ⅰ (13)
Clinical Stage:
Pending (5) Active (11) Discontinued (17)
Bio-Type:
Recombinant enzyme (1) Recombinant cytokines (2)
Company:
Exelixis (1) Genentech (1) Gilead (1) GlaxoSmithKline (6) Jiangsu Hengrui Medicine (1) Janssen (1) Lilly (1) National Institutes of Health (1) Neurocrine Biosciences (2) Novartis (3) Ono Pharmaceutical (1) Onyx Pharmaceutical (2) Pfizer (3) Roche (2) Sanofi (3) Simcere (2) Takeda (1) Virchow Group (1) Clearside Biomedical (1) Qilu Pharmaceutical (1) Advenchen Laboratories (1) BolDere Pharma (1) Nanjing Yoko Biological (1) Italfarmaco (1) China State Institute of Pharmaceutical Industry (CSIPI) (1) AROG Pharmaceuticals (1) NIAAA (2) Proteon Therapeutics (1) QSV Pharma (1) Eddingpharm (1) Jubilant Innovation (1) Zhejiang Medicine (1) Qilu Antibiotics (Linyi) Pharmaceutical (1) Symphony Evolution (1) Mayo Clinic (1) Abbvie (1) Astellas (1) Bayer (4) Boehringer Ingelheim (1) Bristol-Myers Squibb (1) Chiatai Tianqing (CTTQ) (2) ChipScreen (1)
Indication:
Acute lymphoblastic leukaemia (ALL) (1) Acute myeloid Leukemia (AML) (5) Advanced renal cell carcinoma (RCC) (3) Angina pectoris (2) Anxiety (3) Breast cancer (2) Chronic myeloid leukemia (CML ) (1) ischaemic heart disorder (1) Colorectal neoplasms (1) Depression (3) Differentiated thyroid cancer (1) Gastric cancer (2) Gastrointestinal stromal tumors (GISTs) (7) Glioblastoma multiforme (1) Heart failure (2) Hepatocellular carcinoma (HCC) (2) Hypertension (1) Idiopathic pulmonary fibrosis (IPF) (1) Irritable bowel syndrome (IBS) (2) Lung cancer (2) Major depressive disorder (MDD) (1) Medullary thyroid cancer (MTC) (1) Metastatic colorectal cancer (CRC) (2) Multiple myeloma (MM) (1) Myelodysplastic syndrome (MDS) (1) Myocardial infarction (MI) (1) Vascular disorders (1) Neuropathic pain (1) Non small cell lung cancer (NSCLC) (6) Ovarian cancer (5) Peripheral arterial disease (PAD) (1) Renal cell carcinoma (8) Small cell lung cancer (SCLC) (1) Soft tissue infections (1) Soft tissue sarcoma (2) Solid tumours (5) Head and neck cancer (1) Colorectal cancer (1) Aggressive systemic mastocytosis (ASM) (1) Colon cancer (2) Diabetic foot ulcers (1) Systemic mastocytosis with associated hematological neoplasm (1) Mast cell leukemia (1) Age-related macular degeneration (AMD) (1) Unresectable hepatocellular carcinoma (1) Malignant glioma (1) Relapsed or refractory malignant lymphoma (1) Pancreatic neuroendocrine tumors (pNET) (1) Renal carcinoma (3) Post-traumatic stress disorder (2) Lower extremity diabetic neuropathic ulcers (1) Alcoholism (2) Esophagus cancer (1) Advanced gastric adenocarcinoma (1) Aortic valve stenosis (1) Liver cancer (3)
Aprv. Year:
1997 (1) 2006 (2) 2009 (1) 2012 (1) 2014 (1) 2017 (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 3 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top